HOME >> MEDICINE >> NEWS
Studies find that 'broken heart syndrome' can result from opioid withdrawal, cocaine use

Rochester, Minn. -- People who experience abrupt withdrawal from high-dose opioids or use cocaine increase their risk of cardiac event, according to two new studies published in the June issue of Mayo Clinic Proceedings.

The findings shed light on "broken heart syndrome," a still somewhat uncommon disorder first described in Japan 15 years ago that mimics a heart attack. Patients may experience shortness of breath and chest pain and, upon hospital admission, go through extensive tests to determine a diagnosis and rule out heart attack.

In a case report outlined in Mayo Clinic Proceedings this month, physicians describe a 61-year-old woman who was treated for broken heart syndrome at Mayo Clinic Rochester after abruptly discontinuing use of the opioid, OxyContin. It's the first report of broken heart syndrome resulting from opioid withdrawal in an adult.

Opioids such as OxyContin are becoming increasingly common for pain management, the report's authors say. Given the drug's prevalence, physicians should proceed with caution when removing patients from high-dose opioids in order to avoid serious complications and hospitalizations, says Juanita Rivera, M.D., an anesthesiologist with Mayo Clinic Rochester and lead author of the report.

The authors also note the importance of patients being familiar with their medications, as confusion about their drug regimen can delay treatment. Though most broken heart syndrome patients regain full cardiac function, some die and others suffer life-threatening complications.

In a separate case report in June's issue of Mayo Clinic Proceedings, physicians report on the first known case of cocaine use resulting in broken heart syndrome. According to the report, a 54-year-old woman came to the emergency department experiencing chest pain and admitted she had smoked crack cocaine in the months and hours leading up to her admission.

Sandeep Arora, M.D., lead author of the report and an intern
'"/>

Contact: John Murphy
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
21-Jun-2006


Page: 1 2

Related medicine news :

1. Studies show antidepressants not linked to birth defects
2. Studies show role of age, gender, race and weight on cancer risk and treatment
3. Studies suggest investigational agent reduces disease activity in MS
4. Studies highlight advances in diagnosis, medical therapy
5. Studies highlight real world use, safety of drug-eluting stents
6. Studies led by Rhode Island Hospital confirm safety and efficacy
7. Studies identify food sources of disease and drug resistance
8. Studies provide new evidence on risks associated with Cox-2 inhibitors and NSAIDs
9. Studies highlight need to monitor heart function in breast cancer patients
10. Studies examine physician disclosure of medical errors
11. Studies indicate medication can be an effective therapy for smoking cessation

Post Your Comments:
(Date:5/22/2013)... Successful Therapy for Parents program, ... in the Silver Lake community of Los Angeles ... progression to existing Parents and Couples counseling programs. ... therapy has always been suggested, but now it's ... specializes in all aspects of relationships ...
(Date:5/22/2013)... Rapids, IA (PRWEB) May 22, 2013 ... theatre piece Handicap This! The performance promotes awareness ... their dreams. The Handicap This! performance will be held ... Mar High School auditorium. Tickets for Handicap This! ... Handicap This! helps audiences measure the level to which ...
(Date:5/22/2013)... City, UT (PRWEB) May 22, 2013 ... the Alabama Health Insurance Exchange . Zane Benefits, ... sponsored health benefits, is the leader in defined ... , According to Zane Benefits’ website, beginning in 2014 ... insurance coverage for individuals and small businesses will become ...
(Date:5/22/2013)... Over the next two decades, the cost of treating ... than double, topping more than $180 billion a year, ... the increase: an aging population. The report, from the ... was published May 22 in the journal Stroke ... system," Dr. Bruce Ovbiagele, chairman of the department of ...
(Date:5/22/2013)... Award Presented at the 2013 Annual M&A ... http://bit.ly/13DkFfk , Merrill Corporation is pleased to ... of the Year” at the 7th M&A Advisor Turnaround ... in Palm Beach, Florida. , Merrill DataSite is ... solution that optimizes the due diligence process and offers ...
Breaking Medicine News(10 mins):Health News:Patricia O’Laughlin Psychotherapy of Los Angeles Now Seeing Adults, Teens and Young Children 2Health News:Handicap This! Comes to Marion, Iowa 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on Alabama Health Insurance Exchange 3Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 2Health News:Cost of Treating Strokes in U.S. Could Soar to $180B Annually by 2030: Report 3Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 2Health News:Merrill DataSite New Press Release: Merrill DataSite® Virtual Data Room Honored as “Information Management Product/Service of the Year” 3
(Date:5/22/2013)...  The Leukemia & Lymphoma Society (LLS) is committing ... a joint venture between ImmunGene and Caliber, to co-fund ... I clinical trial for a novel fusion protein that ... with indolent lymphomas who do not respond to standard ... is a new class of biotherapeutics produced by fusing ...
(Date:5/22/2013)... 22, 2013 The new 13-valent pneumococcal conjugate ... previous version used prior to 2010, the 7-valent pneumococcal ... published today in Vaccine. The U.S. Food ... 2010 after a series of trials. These trials found ... pneumococcal types than the previously used PCV7, did not ...
(Date:5/22/2013)... NEW YORK , May 22, 2013 ... Gross LLP is investigating claims on behalf of investors ... (NASDAQ: ISRG ) (CUSIP: 46120E602) who purchased ... April 18, 2013 (the "Class Period"). Such investors are ... at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ...
Breaking Medicine Technology:The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 2Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 3Kaiser Permanente Study Finds New Pneumococcal Vaccine Appears to be as Safe as Previously Used Vaccine 4SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG 2
Cached News: